Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations DOI Creative Commons
Stefania Maggi, Odile Launay, Rachel Dawson

et al.

Infectious Diseases and Therapy, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 30, 2024

While marked differences exist between influenza virus, respiratory syncytial virus (RSV), and severe acute syndrome coronavirus 2 (SARS-CoV-2), there is substantial overlap in the vulnerability of populations most at risk for disease following infection, chief among them being advanced age, multiple comorbidities, immunocompromise. Vaccination an established effective preventative strategy to protect against viral infections (RVIs), reducing morbidity mortality, minimizing potential long-term complications, mitigating exacerbation existing health conditions. Despite demonstrated benefits immunization throughout life course recommendations by authorities, coverage rates at-risk vaccine-preventable diseases remain suboptimal vary considerably country demographic strata. The objective this supplement's concluding article discuss current barriers vaccination strategies enhance RVIs adult populations. Identified include low awareness risks diseases, perceived vaccination, doubts regarding vaccine safety, which together contribute hesitancy. Additionally, logistical issues related supply, access, costs present further challenges achieving optimal coverage. Potential overcome these improve uptake strengthening harmonizing guidelines improving surveillance systems appropriately identify needs direct resources. Co-administration or use combination vaccines viruses may be a viable simplifying schedules with future utilization enhanced platforms develop novel vaccines. In addition, vaccination-focused healthcare provider training consumer education are recommended address Reaching targets expanding increasingly achievable availability new updated viruses, but will require collective efforts across providers, policymakers, scientists, officials, general population.

Language: Английский

Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review DOI Creative Commons
Teresa Gavaruzzi, Andrea Ceccarelli, Cristina Nanni

et al.

Vaccines, Journal Year: 2025, Volume and Issue: 13(2), P. 159 - 159

Published: Feb. 6, 2025

Background: New strategies for respiratory syncytial virus (RSV) prevention are available and in development, but their acceptance is crucial to effectiveness. Objectives: This systematic review aims summarize current quantitative qualitative evidence regarding knowledge attitudes relating RSV prevention. Methods: Six databases (PubMed, Scopus, APA PsycArticles; PsycInfo; CINAHL Complete; Psychology Behavioral Sciences Collection) two preprint repositories (medRxiv Preprints) were searched up until 23 December 2024 (PROSPERO: CRD42024602351). Results: Sixty-one articles included, focusing on vaccination the elderly adults at risk (n = 10) or pregnant people 24, of which 8 also examined preferences maternal vs. infant immunization) immunization 27, 16 focused palivizumab, with 6 adherence its monthly administration). Eighteen assessed healthcare professionals. Overall, findings showed limited awareness generally positive towards moderate high intentions uptake rates. Protection against disease perceived severity promoted acceptance, whereas concerns about side effects hindered it. Maternal was more acceptable than immunization. Conclusions: Attitudes options favorable. Should become available, may depend characteristics, how they framed presented. These insights highlight importance education grounded decision-making literature, while recognizing likely favorable reception preventive measures across target age-populations.

Language: Английский

Citations

1
Knowledge, attitude, and perception regarding the respiratory syncytial virus vaccine among healthcare professionals DOI Creative Commons
Khawla Abu Hammour,

Qusai Manaseer,

Mariam Abdeljalil

et al.

Journal of Pharmaceutical Policy and Practice, Journal Year: 2025, Volume and Issue: 18(1)

Published: March 28, 2025

Respiratory syncytial virus (RSV) is a significant respiratory pathogen. Despite vaccine availability, uptake remains low, and healthcare professionals play key role in promoting immunisation. This study aims to evaluate providers' knowledge, perceptions practices regarding the RSV vaccine. A validated survey was distributed professionals. The questionnaire contained sections assess sociodemographic characteristics, knowledge of its vaccines, professionals' perception towards their potential barriers against vaccination. last section assesses physicians' previous practice dealing with infection. Over half participants (56.6%) had no prior awareness RSV, though many recognised severity, particularly vulnerable populations like children older adults (52.6%). Awareness FDA-approved vaccines limited, only 28.1% respondents familiar intended for adults. Views on vaccination recommendations age groups were divided; 23.7% supported those 75 older, while 31.1% advocated aged 60-74 at higher risk. Perceived prominent. Most (85.1%) cited concerns about safety as obstacle, 81.1% identified out-of-pocket costs barrier. Testing infrequent (24.6%), mainly due lack effective treatment. (96.9%) called greater education 91.2% recommending if it available free. reveals gaps substantial adoption. Targeted education, improved diagnostics, addressing are essential strategies improving response RSV.

Language: Английский

Citations

0
Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk Populations DOI Creative Commons
Stefania Maggi, Odile Launay, Rachel Dawson

et al.

Infectious Diseases and Therapy, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 30, 2024

While marked differences exist between influenza virus, respiratory syncytial virus (RSV), and severe acute syndrome coronavirus 2 (SARS-CoV-2), there is substantial overlap in the vulnerability of populations most at risk for disease following infection, chief among them being advanced age, multiple comorbidities, immunocompromise. Vaccination an established effective preventative strategy to protect against viral infections (RVIs), reducing morbidity mortality, minimizing potential long-term complications, mitigating exacerbation existing health conditions. Despite demonstrated benefits immunization throughout life course recommendations by authorities, coverage rates at-risk vaccine-preventable diseases remain suboptimal vary considerably country demographic strata. The objective this supplement's concluding article discuss current barriers vaccination strategies enhance RVIs adult populations. Identified include low awareness risks diseases, perceived vaccination, doubts regarding vaccine safety, which together contribute hesitancy. Additionally, logistical issues related supply, access, costs present further challenges achieving optimal coverage. Potential overcome these improve uptake strengthening harmonizing guidelines improving surveillance systems appropriately identify needs direct resources. Co-administration or use combination vaccines viruses may be a viable simplifying schedules with future utilization enhanced platforms develop novel vaccines. In addition, vaccination-focused healthcare provider training consumer education are recommended address Reaching targets expanding increasingly achievable availability new updated viruses, but will require collective efforts across providers, policymakers, scientists, officials, general population.

Language: Английский

Citations

2